Cargando…

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms

BACKGROUND AND OBJECTIVES: Cortical structural changes in major depressive disorder (MDD) are usually studied using a voxel-based morphometry approach to delineate the cortical gray matter volume. Among cortical structures, gyrification patterns are considered a relatively stable indicator. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Natsuyama, Tomoya, Okamoto, Naomichi, Watanabe, Keita, Chibaatar, Enkhmurun, Tesen, Hirofumi, Hayasaki, Gaku, Ikenouchi, Atsuko, Kakeda, Shingo, Yoshimura, Reiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852994/
https://www.ncbi.nlm.nih.gov/pubmed/36684011
http://dx.doi.org/10.3389/fpsyt.2022.1031386
_version_ 1784872792914657280
author Natsuyama, Tomoya
Okamoto, Naomichi
Watanabe, Keita
Chibaatar, Enkhmurun
Tesen, Hirofumi
Hayasaki, Gaku
Ikenouchi, Atsuko
Kakeda, Shingo
Yoshimura, Reiji
author_facet Natsuyama, Tomoya
Okamoto, Naomichi
Watanabe, Keita
Chibaatar, Enkhmurun
Tesen, Hirofumi
Hayasaki, Gaku
Ikenouchi, Atsuko
Kakeda, Shingo
Yoshimura, Reiji
author_sort Natsuyama, Tomoya
collection PubMed
description BACKGROUND AND OBJECTIVES: Cortical structural changes in major depressive disorder (MDD) are usually studied using a voxel-based morphometry approach to delineate the cortical gray matter volume. Among cortical structures, gyrification patterns are considered a relatively stable indicator. In this study, we investigated differences in gyrification patterns between MDD patients and healthy controls (HCs) and explored the association of gyrification patterns with plasma brain-derived neurotrophic factor (BDNF) levels and depressive symptoms in MDD patients. METHODS: We evaluated 79 MDD patients and 94 HCs and assessed depression severity in the patients using the 17-item Hamilton Depression Rating Scale (HAM-D). Blood samples of both groups were collected to measure plasma BDNF levels. Magnetic resonance imaging (MRI) data were obtained using three-dimensional fast-spoiled gradient-recalled acquisition. Differences in plasma BDNF levels between groups were examined using the Mann–Whitney U test. Principal component analysis and orthogonal partial least squares discriminant analysis (OPLS-DA) were conducted to investigate the gyrification patterns which were significantly different between the groups, i.e., those with variable importance in projection (VIP) scores of >1.5 and p-value < 0.05 in multiple regression analyses adjusted for age and sex. Finally, multiple regression analysis was performed on the selected gyrification patterns to examine their association with BDNF levels in the two groups and HAM-D in the patients. RESULTS: There were no significant differences in plasma BDNF levels between the groups. We found that 108 (71.0%) of 152 total local gyrification indices were MDD < HC. We identified 10 disease-differentiating factors based on critical gyrification features (VIP > 1.5 and p-value adjusted for age and sex < 0.05). However, we found no significant correlations between the 10 gyrification patterns and plasma BDNF levels and no interaction with group. Moreover, no significant correlations were observed between the local gyrification indices and HAM-D total scores. CONCLUSION: These results suggest that abnormal early cortical neurodevelopment may mediate vulnerability to MDD, independent of plasma BDNF levels and depressive symptoms.
format Online
Article
Text
id pubmed-9852994
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98529942023-01-21 Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms Natsuyama, Tomoya Okamoto, Naomichi Watanabe, Keita Chibaatar, Enkhmurun Tesen, Hirofumi Hayasaki, Gaku Ikenouchi, Atsuko Kakeda, Shingo Yoshimura, Reiji Front Psychiatry Psychiatry BACKGROUND AND OBJECTIVES: Cortical structural changes in major depressive disorder (MDD) are usually studied using a voxel-based morphometry approach to delineate the cortical gray matter volume. Among cortical structures, gyrification patterns are considered a relatively stable indicator. In this study, we investigated differences in gyrification patterns between MDD patients and healthy controls (HCs) and explored the association of gyrification patterns with plasma brain-derived neurotrophic factor (BDNF) levels and depressive symptoms in MDD patients. METHODS: We evaluated 79 MDD patients and 94 HCs and assessed depression severity in the patients using the 17-item Hamilton Depression Rating Scale (HAM-D). Blood samples of both groups were collected to measure plasma BDNF levels. Magnetic resonance imaging (MRI) data were obtained using three-dimensional fast-spoiled gradient-recalled acquisition. Differences in plasma BDNF levels between groups were examined using the Mann–Whitney U test. Principal component analysis and orthogonal partial least squares discriminant analysis (OPLS-DA) were conducted to investigate the gyrification patterns which were significantly different between the groups, i.e., those with variable importance in projection (VIP) scores of >1.5 and p-value < 0.05 in multiple regression analyses adjusted for age and sex. Finally, multiple regression analysis was performed on the selected gyrification patterns to examine their association with BDNF levels in the two groups and HAM-D in the patients. RESULTS: There were no significant differences in plasma BDNF levels between the groups. We found that 108 (71.0%) of 152 total local gyrification indices were MDD < HC. We identified 10 disease-differentiating factors based on critical gyrification features (VIP > 1.5 and p-value adjusted for age and sex < 0.05). However, we found no significant correlations between the 10 gyrification patterns and plasma BDNF levels and no interaction with group. Moreover, no significant correlations were observed between the local gyrification indices and HAM-D total scores. CONCLUSION: These results suggest that abnormal early cortical neurodevelopment may mediate vulnerability to MDD, independent of plasma BDNF levels and depressive symptoms. Frontiers Media S.A. 2023-01-06 /pmc/articles/PMC9852994/ /pubmed/36684011 http://dx.doi.org/10.3389/fpsyt.2022.1031386 Text en Copyright © 2023 Natsuyama, Okamoto, Watanabe, Chibaatar, Tesen, Hayasaki, Ikenouchi, Kakeda and Yoshimura. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Natsuyama, Tomoya
Okamoto, Naomichi
Watanabe, Keita
Chibaatar, Enkhmurun
Tesen, Hirofumi
Hayasaki, Gaku
Ikenouchi, Atsuko
Kakeda, Shingo
Yoshimura, Reiji
Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
title Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
title_full Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
title_fullStr Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
title_full_unstemmed Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
title_short Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
title_sort gyrification patterns in first-episode, drug-naïve major depression: associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852994/
https://www.ncbi.nlm.nih.gov/pubmed/36684011
http://dx.doi.org/10.3389/fpsyt.2022.1031386
work_keys_str_mv AT natsuyamatomoya gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms
AT okamotonaomichi gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms
AT watanabekeita gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms
AT chibaatarenkhmurun gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms
AT tesenhirofumi gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms
AT hayasakigaku gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms
AT ikenouchiatsuko gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms
AT kakedashingo gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms
AT yoshimurareiji gyrificationpatternsinfirstepisodedrugnaivemajordepressionassociationswithplasmalevelsofbrainderivedneurotrophicfactorandpsychiatricsymptoms